APR and Labtec have regained the marketing and commercialization rights of Ondansetron Oral Dispersible Film (“ODF”) together with the brand name “Setofilm®” after the termination of the former license agreement with the French Company BioAlliance. More
Two out of the eight awards presented for the first ever CIHR-CMAJ Top Canadian Achievements in Health Research Awards have gone to faculty members at The University of Western Ontario. More
Morphochem and GBF have entered into a research collaboration in the area of cancer research, the objective of which is to develop new therapeutics using tubulysins. More
For the first time in the history of Korean bio-pharmaceutical technology exports, technology transfer is made to Germany / A new osteoporosis cure concept with fundamental prevention and treatment More